Expertise in
48
conditions

Dr. Todd D. Shenkenberg

Oncology
Valley Cancer Associates
1719 Treasure Hills Blvd, 
Harlingen, TX 
Accepting New Patients
Expertise in
48
conditions
Valley Cancer Associates
1719 Treasure Hills Blvd, 
Harlingen, TX 

Overview

Todd Shenkenberg is an Oncologist practicing medicine in Harlingen, Texas.

Dr. Shenkenberg is highly rated in 48 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Hemangioma Thrombocytopenia Syndrome, Gastrostomy, and Endoscopy.

He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 3 clinical trials. Dr. Shenkenberg is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in TX

Hospital Affiliations

Vhs Harlingen Hospital Company LLC
Harlingen Medical Center
Valley Regional Medical Center
Valley Baptist Medical Center- Brownsville
Doctors Hosptal At Renaissance

Languages Spoken

English
Arabic
German
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health Options
  • PPO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

Valley Cancer Associates
1719 Treasure Hills Blvd, Harlingen, TX 78550

Additional Areas of Focus

Dr. Shenkenberg has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 2 Study to Evaluate the Safety and Efficacy of Lerociclib in Participants With Advanced Breast Cancer
A Phase 2 Study to Evaluate the Safety and Efficacy of Lerociclib in Participants With Advanced Breast Cancer
Enrollment Status: Terminated
Publish Date: May 14, 2026
Intervention Type: Drug
Study Drugs: Lerociclib, Letrozole, Fulvestrant
Study Phase: Phase 2
A Phase 2, Randomized, Open-Label Study of Trilaciclib Administered With First-Line Platinum-Based Chemotherapy and Avelumab Maintenance Therapy in Patients With Untreated, Locally Advanced or Metastatic Urothelial Carcinoma (PRESERVE 3)
A Phase 2, Randomized, Open-Label Study of Trilaciclib Administered With First-Line Platinum-Based Chemotherapy and Avelumab Maintenance Therapy in Patients With Untreated, Locally Advanced or Metastatic Urothelial Carcinoma (PRESERVE 3)
Enrollment Status: Terminated
Publish Date: September 08, 2025
Intervention Type: Drug
Study Drugs: Trilaciclib, Gemcitabine, Cisplatin, Carboplatin, Avelumab
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled Trial of Tomivosertib in Combination With Anti-PD-(L)1 Therapy in Subjects With NSCLC as First Line Therapy or When Progressing on Single-Agent First-Line Anti PD (L)1 Therapy
A Randomized, Double-Blind, Placebo-Controlled Trial of Tomivosertib in Combination With Anti-PD-(L)1 Therapy in Subjects With NSCLC as First Line Therapy or When Progressing on Single-Agent First-Line Anti PD (L)1 Therapy
Enrollment Status: Unknown
Publish Date: April 30, 2024
Intervention Type: Biological, Drug
Study Drugs: Tomivosertib, Pembrolizumab
Study Phase: Phase 2
View 2 Less Clinical Trials

2 Total Publications

Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the PREDAPT study.
Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the PREDAPT study.
Journal: Journal for immunotherapy of cancer
Published: October 05, 2024
Similar Doctors
Expertise in
17
conditions
Expertise in
17
conditions
Referral may be required

Texas Oncology - Brownsville

2150 N Expressway # 83, 
Brownsville, TX 
 (18.7 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Marcelo Boek is an Oncologist practicing medicine in Brownsville, Texas. Dr. Boek is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Thrombocytopenia, Thyroid Cancer, Anaplastic Thyroid Cancer, and Bone Marrow Aspiration. Dr. Boek is currently accepting new patients.

Expertise in
12
conditions
Expertise in
12
conditions
Referral may be required

Dhr Health Hematology Oncology Institute-Edinburg

2717 Michaelangelo Dr Ste 200, 
Edinburg, TX 
 (32.8 miles away)
956-362-2250
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Terence Herman is an Oncologist practicing medicine in Edinburg, Texas. Dr. Herman is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Vulvar Cancer, Gliomatosis Cerebri, and Bone Marrow Aspiration. Dr. Herman is currently accepting new patients.

Expertise in
16
conditions
Expertise in
16
conditions
Referral may be required

Texas Oncology - Brownsville

2150 N Expressway # 83, 
Brownsville, TX 
 (18.7 miles away)
Languages Spoken:
English, Hindi, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Balesh Sharma is an Oncologist practicing medicine in Brownsville, Texas. Dr. Sharma is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Paget Disease of the Breast, Breast Cancer, Familial Colorectal Cancer, and Bone Marrow Aspiration. Dr. Sharma is currently accepting new patients.

Frequently Asked Questions about Dr. Todd D. Shenkenberg

How do I make an appointment with Dr. Todd D. Shenkenberg?

You can book an appointment with Dr. Todd D. Shenkenberg by calling their office at 956-364-2131. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Todd D. Shenkenberg a top-rated expert for Paget Disease of the Breast?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Todd D. Shenkenberg is classified as an Distinguished expert for Paget Disease of the Breast, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Todd D. Shenkenberg specialize in?

While Dr. Todd D. Shenkenberg is a Oncology, they have specific expertise in Paget Disease of the Breast, Breast Cancer, and Hemangioma Thrombocytopenia Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Todd D. Shenkenberg participate in research or clinical trials?

Yes. Dr. Todd D. Shenkenberg has published 2 articles and abstracts on conditions like Paget Disease of the Breast. You can view a list of Dr. Todd D. Shenkenberg's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Todd D. Shenkenberg accept my insurance?

Dr. Todd D. Shenkenberg accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 956-364-2131 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Shenkenberg's expertise for a condition
ConditionClose
    View All 44 Advanced Conditions
    View All 101 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile